ATLASCytokinetics (CYTK) earnings date: Nov 4, 2026
Cytokinetics (CYTK) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026 (confirmed), after the close. Analysts expect EPS of -$1.41. Free email alerts for this report are just below.
Source: company filings and exchange data · Updated Nov 3, 2026
ATLAS view on CYTK
| Last price | $62.03 (-1.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.2% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Cytokinetics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get an email before and after Cytokinetics reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountCYTK earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.41 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 3 reports) | 1 of 3 (33%) |
| Average EPS surprise | -48.3% |
| Average move around a report | ±5.3% (last 3) |
| Sector | Healthcare · Biotechnology |
Cytokinetics earnings history: last 3 reports
Cytokinetics last reported on Aug 6, 2026: EPS of -$1.50 against an estimate of -$1.60 (+6.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$1.60 | -$1.50 | +6.3% | Beat | -2.7% |
| Jul 9, 2026 | $0.04 | -$0.02 | -150.0% | Miss | 0.0% |
| May 5, 2026 | -$1.65 | -$1.67 | -1.2% | In line | +13.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CYTK
See the fair value, the probability range and the earnings history of Cytokinetics on its ATLAS page.
Cytokinetics (CYTK) stock analysisPlans from €3.99 a month.
Cytokinetics earnings: frequently asked questions
When does Cytokinetics (CYTK) report earnings?
Cytokinetics is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CYTK?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.41 per share (USD). Estimates can change before the report.
How often does CYTK beat earnings estimates?
Of its last 3 reports with a recorded result, Cytokinetics beat the EPS estimate 1 times; the average surprise was -48.3%. Past results do not predict the next one.
How much does CYTK move around earnings?
Over its last 3 reports the stock moved an average of 5.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 3 times.
Did Cytokinetics beat earnings estimates last quarter?
Cytokinetics last reported on Aug 6, 2026: EPS of -$1.50 against an estimate of -$1.60 (+6.3% surprise), a beat.
How much does CYTK usually move in a day?
On a normal trading day the ATLAS model puts CYTK’s one-day range at about ±2.2%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer